IndraLab

Statements

CYLD deubiquitinates SMAD7. 3 / 3

1 | 2

"This showed that CYLD can bind to SMAD7 and deubiquitinate SMAD7 at Lysine 360 and 374 residues, which are required for the activation of TAK1 and p38 signaling"

24756567

➶

reach

"CYLD deubiquitinates Smad7 and inhibits TGF-β signaling (58)."

30386338

➶

reach

"CYLD deubiquitinates Smad7 and thereby inhibits the activation of TAK1 and p38, thus inhibiting the TGFbeta induced development of regulatory T cells."

22335355

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

CYLD deubiquitinates SMAD7. 3 / 3

INDRA sources:

Databases

Reading